Reduction in colposcopy workload and associated clinical activity following human papillomavirus (HPV) catch-up vaccination programme in Scotland: an ecological study

被引:16
|
作者
Cruickshank, M. E. [1 ]
Pan, J. [2 ]
Cotton, S. C. [1 ]
Kavanagh, K. [2 ]
Robertson, C. [2 ,3 ]
Cuschieri, K. [4 ]
Cubie, H. [4 ]
Palmer, T. [5 ]
Pollock, K. G. [3 ]
机构
[1] Univ Aberdeen, Dept Obstet & Gynaecol, Aberdeen, Scotland
[2] Univ Strathclyde, Dept Math & Stat, Glasgow, Lanark, Scotland
[3] Hlth Protect Scotland, Glasgow, Lanark, Scotland
[4] Scottish Human Papillomavirus Reference Lab, Edinburgh, Midlothian, Scotland
[5] Univ Edinburgh, Dept Pathol, Edinburgh, Midlothian, Scotland
关键词
Cervical screening; colposcopy; HPV; HPV vaccine; immunisation; loop excision; PERIMORTEM CESAREAN DELIVERY; CARDIAC-ARREST; CARDIOPULMONARY-RESUSCITATION; PREGNANCY;
D O I
10.1111/1471-0528.14562
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective To measure patterns of clinical activity at colposcopy before and after vaccinated women entered the Scottish Cervical Screening Programme (SCSP). Design Population-based observational study using nationally collected data. Setting Scottish colposcopy clinics. Sample All women with a date of birth on or after 1 January 1985 who attended colposcopy in Scotland between 2008 and 2014. Methods Routinely collected data from the Scottish National Colposcopy Clinical Information Audit System (NCCIAS) were extracted, including: referral criteria, referral cervical cytology, colposcopic findings, clinical procedures, and histology results. Analysis was restricted to those referred to colposcopy at age 20 or 21 years. Main outcome measures Referral criteria, positive predictive value of colposcopy, default rates, and rates of cervical biopsies and treatments. Results A total of 7372 women referred for colposcopy at age 20 or 21 years were identified. There was a downward trend in the proportion of those referred with abnormal cytology (2008/9, 91.0%; 2013/14, 90.3%; linear trend P = 0.03). Women were less likely to have diagnostic or therapeutic interventions. The proportion with no biopsy (2008/9, 19.5%; 2013/14, 26.9%; linear trend P < 0.0001) and no treatment (2008/9, 74.9%; 2013/14, 91.8%; linear trend P < 0.0001) increased over the period of observation. Conclusions A reduction in clinical activity related to abnormal screening referrals is likely to be associated with the human papillomavirus (HPV) catch-up immunisation programme. Referral criteria and the service provision of colposcopy needs to be planned carefully, taking account of the increasing number of women who have been immunised against HPV that will be entering cervical screening programmes worldwide.
引用
收藏
页码:1386 / 1393
页数:8
相关论文
共 10 条
  • [1] Factors Associated With Human Papillomavirus Vaccination Completion on a Catch-Up Schedule
    Perry, Rachel
    Rankin, Kristin
    Yu, Miao Crystal
    Harwood, Bryna
    OBSTETRICS AND GYNECOLOGY, 2014, 124 (01): : 76 - 81
  • [2] The impact of human papillomavirus type on colposcopy performance in women offered HPV immunisation in a catch-up vaccine programme: a two-centre observational study
    Munro, A.
    Gillespie, C.
    Cotton, S.
    Busby-Earle, C.
    Kavanagh, K.
    Cuschieri, K.
    Cubie, H.
    Robertson, C.
    Smart, L.
    Pollock, K.
    Moore, C.
    Palmer, T.
    Cruickshank, M. E.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2017, 124 (09) : 1394 - 1401
  • [3] Factors Associated with College Students' Human Papillomavirus (HPV) Vaccination and Preferred Strategies for Catch-Up Vaccine Promotion: A Mixed-Methods Study
    Jin, Seok Won
    Lee, Yeonggeul
    Lee, Sohye
    Jin, Haeun
    Brandt, Heather M.
    VACCINES, 2023, 11 (06)
  • [4] The impact of catch-up bivalent human papillomavirus vaccination on cervical screening outcomes: an observational study from the English HPV primary screening pilot
    Matejka Rebolj
    Francesca Pesola
    Christopher Mathews
    David Mesher
    Kate Soldan
    Henry Kitchener
    British Journal of Cancer, 2022, 127 : 278 - 287
  • [5] The impact of catch-up bivalent human papillomavirus vaccination on cervical screening outcomes: an observational study from the English HPV primary screening pilot
    Rebolj, Matejka
    Pesola, Francesca
    Mathews, Christopher
    Mesher, David
    Soldan, Kate
    Kitchener, Henry
    BRITISH JOURNAL OF CANCER, 2022, 127 (02) : 278 - 287
  • [6] Impact of catch-up human papillomavirus vaccination on cervical cancer incidence in Kenya: A mathematical modeling evaluation of HPV vaccination strategies in the context of moderate HIV prevalence
    Liu, Gui
    Mugo, Nelly R.
    Bayer, Cara
    Rao, Darcy White
    Onono, Maricianah
    Mgodi, Nyaradzo M.
    Chirenje, Zvavahera M.
    Njoroge, Betty W.
    Tan, Nicholas
    Bukusi, Elizabeth A.
    Barnabas, Ruanne, V
    ECLINICALMEDICINE, 2022, 45
  • [7] Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study
    Kavanagh, Kimberley
    Pollock, Kevin G.
    Cuschieri, Kate
    Palmer, Tim
    Cameron, Ross L.
    Watt, Cameron
    Bhatia, Ramya
    Moore, Catherine
    Cubie, Heather
    Cruickshank, Margaret
    Robertson, Chris
    LANCET INFECTIOUS DISEASES, 2017, 17 (12): : 1293 - 1302
  • [8] Human Papillomavirus Vaccine Course Completion Among Gay and Bisexual Men Who Have Sex With Men From a Time-Limited HPV Vaccination Catch-Up Program in Victoria, Australia
    Htaik, Kay
    Fairley, Christopher K. K.
    Chen, Marcus Y. Y.
    Wigan, Rebecca
    Rodriguez, Elena
    Bradshaw, Catriona S. S.
    Chow, Eric P. F.
    FRONTIERS IN PUBLIC HEALTH, 2021, 9
  • [9] Effectiveness of catch-up human papillomavirus vaccination on incident cervical neoplasia in a US health-care setting: a population-based case-control study
    Silverberg, Michael J.
    Leyden, Wendy A.
    Lam, Jennifer O.
    Gregorich, Steven E.
    Huchko, Megan J.
    Kulasingam, Shalini
    Kuppermann, Miriam
    Smith-McCune, Karen K.
    Sawaya, George F.
    LANCET CHILD & ADOLESCENT HEALTH, 2018, 2 (10): : 707 - 714
  • [10] RAPID FALL IN QUADRIVALENT VACCINE TARGETED HUMAN PAPILLOMAVIRUS GENOTYPES IN HETEROSEXUAL MEN FOLLOWING THE AUSTRALIAN FEMALE HPV VACCINATION PROGRAMME: AN OBSERVATIONAL STUDY FROM 2004 TO 2015
    Chow, Eric
    Machalek, Dorothy
    Tabrizi, Sepehr
    Danielewski, Jennifer
    Fehler, Glenda
    Bradshaw, Catriona
    Garland, Suzanne
    Chen, Marcus
    Fairley, Christopher
    Walker, Sandra
    SEXUALLY TRANSMITTED INFECTIONS, 2016, 92 : A10 - A11